Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Acura Pharmaceuticals, Inc. stock logo
ACUR
Acura Pharmaceuticals
$0.01
$0.00
$0.00
$0.05
$663K1.892,979 shsN/A
Auris Medical Holding Ltd. stock logo
EARS
Auris Medical
$1.44
-8.9%
$2.88
$0.73
$6.60
$16.44M1.173.10 million shs2.98 million shs
iCo Therapeutics Inc. stock logo
ICOTF
iCo Therapeutics
$0.34
-5.5%
$0.37
$0.80
$1.82
$3.09M2.034,760 shs1,200 shs
International Stem Cell Co. stock logo
ISCO
International Stem Cell
$0.07
$0.09
$0.05
$0.17
N/A0.522,342 shs1,566 shs
Kaya Holdings, Inc. stock logo
KAYS
Kaya
$0.03
$0.04
$0.03
$0.09
$412K0.584,564 shs13,747 shs
10 Best Cheap Stocks to Buy Now Cover

MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Click the link below to see which companies made the list.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Acura Pharmaceuticals, Inc. stock logo
ACUR
Acura Pharmaceuticals
0.00%+257.14%+185.71%+733.33%-80.00%
Auris Medical Holding Ltd. stock logo
EARS
Auris Medical
-8.86%-2.70%-16.76%-36.84%+34.58%
iCo Therapeutics Inc. stock logo
ICOTF
iCo Therapeutics
-5.31%-7.92%-5.36%-13.49%-33.84%
International Stem Cell Co. stock logo
ISCO
International Stem Cell
-14.04%-14.04%-38.80%-24.54%-66.00%
Kaya Holdings, Inc. stock logo
KAYS
Kaya
+4.29%-5.81%-18.89%-32.87%-46.52%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Acura Pharmaceuticals, Inc. stock logo
ACUR
Acura Pharmaceuticals
N/AN/AN/AN/AN/AN/AN/AN/A
Auris Medical Holding Ltd. stock logo
EARS
Auris Medical
N/AN/AN/AN/AN/AN/AN/AN/A
iCo Therapeutics Inc. stock logo
ICOTF
iCo Therapeutics
N/AN/AN/AN/AN/AN/AN/AN/A
International Stem Cell Co. stock logo
ISCO
International Stem Cell
N/AN/AN/AN/AN/AN/AN/AN/A
Kaya Holdings, Inc. stock logo
KAYS
Kaya
N/AN/AN/AN/AN/AN/AN/AN/A

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Acura Pharmaceuticals, Inc. stock logo
ACUR
Acura Pharmaceuticals
N/AN/AN/AN/A
Auris Medical Holding Ltd. stock logo
EARS
Auris Medical
N/AN/AN/AN/A
iCo Therapeutics Inc. stock logo
ICOTF
iCo Therapeutics
N/AN/AN/AN/A
International Stem Cell Co. stock logo
ISCO
International Stem Cell
N/AN/AN/AN/A
Kaya Holdings, Inc. stock logo
KAYS
Kaya
N/AN/AN/AN/A

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Acura Pharmaceuticals, Inc. stock logo
ACUR
Acura Pharmaceuticals
$1.56M0.43N/AN/AN/A
Auris Medical Holding Ltd. stock logo
EARS
Auris Medical
N/AN/AN/AN/A$1.57 per shareN/A
iCo Therapeutics Inc. stock logo
ICOTF
iCo Therapeutics
N/AN/AN/AN/A($0.07) per shareN/A
International Stem Cell Co. stock logo
ISCO
International Stem Cell
$7.79MN/AN/AN/A($0.57) per shareN/A
Kaya Holdings, Inc. stock logo
KAYS
Kaya
$200K2.06$0.11 per share0.25($1.07) per share-0.03

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Acura Pharmaceuticals, Inc. stock logo
ACUR
Acura Pharmaceuticals
-$880KN/A0.00N/AN/AN/AN/AN/A
Auris Medical Holding Ltd. stock logo
EARS
Auris Medical
-$8.75MN/A0.00N/AN/AN/AN/AN/A
iCo Therapeutics Inc. stock logo
ICOTF
iCo Therapeutics
-$1.11M-$0.40N/AN/AN/AN/A-288.85%N/A
International Stem Cell Co. stock logo
ISCO
International Stem Cell
-$130K-$0.03N/AN/A-2.68%-2.80%-3.77%N/A
Kaya Holdings, Inc. stock logo
KAYS
Kaya
$1.61M-$0.02N/AN/A821.43%-9.57%638.26%4/26/2024 (Estimated)

Latest EARS, ISCO, ICOTF, ACUR, and KAYS Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
4/16/2024Q4 2023
Kaya Holdings, Inc. stock logo
KAYS
Kaya
N/A$0.01+$0.01$0.01N/A$0.03 million
3/28/2024Q4 2023
International Stem Cell Co. stock logo
ISCO
International Stem Cell
N/A-$0.04-$0.04-$0.04N/A$1.89 million

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Acura Pharmaceuticals, Inc. stock logo
ACUR
Acura Pharmaceuticals
N/AN/AN/AN/AN/A
Auris Medical Holding Ltd. stock logo
EARS
Auris Medical
N/AN/AN/AN/AN/A
iCo Therapeutics Inc. stock logo
ICOTF
iCo Therapeutics
N/AN/AN/AN/AN/A
International Stem Cell Co. stock logo
ISCO
International Stem Cell
N/AN/AN/AN/AN/A
Kaya Holdings, Inc. stock logo
KAYS
Kaya
N/AN/AN/AN/AN/A

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Acura Pharmaceuticals, Inc. stock logo
ACUR
Acura Pharmaceuticals
N/AN/AN/A
Auris Medical Holding Ltd. stock logo
EARS
Auris Medical
N/A
3.83
3.83
iCo Therapeutics Inc. stock logo
ICOTF
iCo Therapeutics
N/A
0.72
0.72
International Stem Cell Co. stock logo
ISCO
International Stem Cell
N/A
0.73
0.47
Kaya Holdings, Inc. stock logo
KAYS
Kaya
N/A
0.01
0.01

Ownership

Institutional Ownership

CompanyInstitutional Ownership
Acura Pharmaceuticals, Inc. stock logo
ACUR
Acura Pharmaceuticals
N/A
Auris Medical Holding Ltd. stock logo
EARS
Auris Medical
6.03%
iCo Therapeutics Inc. stock logo
ICOTF
iCo Therapeutics
N/A
International Stem Cell Co. stock logo
ISCO
International Stem Cell
N/A
Kaya Holdings, Inc. stock logo
KAYS
Kaya
N/A

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Acura Pharmaceuticals, Inc. stock logo
ACUR
Acura Pharmaceuticals
966.35 million52.95 millionNot Optionable
Auris Medical Holding Ltd. stock logo
EARS
Auris Medical
132,20011.42 millionN/ANot Optionable
iCo Therapeutics Inc. stock logo
ICOTF
iCo Therapeutics
N/A9.05 millionN/ANot Optionable
International Stem Cell Co. stock logo
ISCO
International Stem Cell
29N/AN/ANot Optionable
Kaya Holdings, Inc. stock logo
KAYS
Kaya
414.72 million11.26 millionNot Optionable

EARS, ISCO, ICOTF, ACUR, and KAYS Headlines

SourceHeadline
Nick Carter Allegations, Aaron Carter Controversies to Be Addressed in Fallen Idols Docuseries Coming to IDNick Carter Allegations, Aaron Carter Controversies to Be Addressed in 'Fallen Idols' Docuseries Coming to ID
people.com - April 24 at 10:07 PM
Turkeys famed Van cats see birthrates surgeTurkey's famed Van cats see birthrates surge
al-monitor.com - April 24 at 5:07 PM
Wildcats fall to Ed-Co, top AlburnettWildcats fall to Ed-Co, top Alburnett
manchesterpress.com - April 24 at 7:23 AM
Class OK’d in suit alleging religious exercise in schoolsClass OK’d in suit alleging religious exercise in schools
chicagolawbulletin.com - April 23 at 9:05 PM
Carra Patterson Says Kaya’s Suspicious of Both Elsbeth & Wagner on ‘Elsbeth’Carra Patterson Says Kaya’s Suspicious of Both Elsbeth & Wagner on ‘Elsbeth’
msn.com - April 23 at 3:44 PM
High school softball: Brudos leads West Salem in win over La Crosse LoganHigh school softball: Brudos leads West Salem in win over La Crosse Logan
lacrossetribune.com - April 22 at 11:53 PM
In ‘Witness,’ Aspen Words Literary Prize finalist Jamel Brinkley explores ‘vital moments’ of observation and actionIn ‘Witness,’ Aspen Words Literary Prize finalist Jamel Brinkley explores ‘vital moments’ of observation and action
aspenpublicradio.org - April 22 at 10:52 PM
Kaya Scodelario interview: ‘The GentlemenKaya Scodelario interview: ‘The Gentlemen'
msn.com - April 22 at 5:52 PM
Kaya Scodelario (The Gentlemen) on playing a real boss bitch not defined by her sexualityKaya Scodelario ('The Gentlemen') on playing 'a real boss bitch' not defined by her sexuality
yahoo.com - April 22 at 5:52 PM
Pagasa: Brighter skies in Luzon, Visayas as heat persists due to HPAPagasa: Brighter skies in Luzon, Visayas as heat persists due to HPA
msn.com - April 21 at 9:05 PM
Are restaurant service charges a tipping point for change?Are restaurant service charges a tipping point for change?
msn.com - April 21 at 8:51 AM
Brownwoods Kaya Phillips leads Abilene-area performers in Regions I-4A/5A track meetBrownwood's Kaya Phillips leads Abilene-area performers in Regions I-4A/5A track meet
msn.com - April 21 at 8:51 AM
‘Elsbeth’ Season 1 Episode 6 Preview: Photos, “Ear for an Ear” Promo and Cast‘Elsbeth’ Season 1 Episode 6 Preview: Photos, “Ear for an Ear” Promo and Cast
showbizjunkies.com - April 20 at 12:48 AM
What It’s Like to Stay at Kaya Palazzo Ski & Mountain Resort, Turkey’s Answer to AspenWhat It’s Like to Stay at Kaya Palazzo Ski & Mountain Resort, Turkey’s Answer to Aspen
robbreport.com - April 19 at 2:48 PM
Orlando’s Michelin galaxy expands with four new starsOrlando’s Michelin galaxy expands with four new stars
msn.com - April 19 at 7:41 AM
MBARI Names Kaya Johnson Director of Marine OperationsMBARI Names Kaya Johnson Director of Marine Operations
marinetechnologynews.com - April 18 at 2:18 PM
In ‘Temple Folk,’ Aspen Words Literary Prize finalist Aaliyah Bilal pursues ‘the practice of empathy through literature’In ‘Temple Folk,’ Aspen Words Literary Prize finalist Aaliyah Bilal pursues ‘the practice of empathy through literature’
aspenpublicradio.org - April 18 at 9:18 AM
Kaya Werley powers Wilson WL past Fleetwood with 3 home runsKaya Werley powers Wilson WL past Fleetwood with 3 home runs
wfmz.com - April 18 at 9:18 AM
Tuesdays Prep Roundup: Anacortes girls tennis team sweeps Sedro-WoolleyTuesday's Prep Roundup: Anacortes girls' tennis team sweeps Sedro-Woolley
goskagit.com - April 17 at 2:03 PM
KAYS Stock Earnings: Kaya Holdings Reported Results for Q4 2023KAYS Stock Earnings: Kaya Holdings Reported Results for Q4 2023
msn.com - April 17 at 12:48 AM
Here are Orlandos best restaurants, as named by Fodors Travel guideHere are Orlando's best restaurants, as named by Fodor's Travel guide
bizjournals.com - April 15 at 7:19 PM
‘The Gentlemen Stars Theo James, Kaya Scodelario & Daniel Ings Talk Prospect Of Second Season For Guy Ritchies Netflix Series - Contenders TV‘The Gentlemen' Stars Theo James, Kaya Scodelario & Daniel Ings Talk Prospect Of Second Season For Guy Ritchie's Netflix Series - Contenders TV
msn.com - April 15 at 3:37 PM
Marvin Agustin, pabirong nag-react sa pagkakilig ni Jolina Magdangal kay Kim Seon Ho: "Kaya pala"Marvin Agustin, pabirong nag-react sa pagkakilig ni Jolina Magdangal kay Kim Seon Ho: "Kaya pala"
msn.com - April 15 at 8:58 AM
18 Behind-The-Scenes Secrets You Probably Didn’t Know About The Gentlemen18 Behind-The-Scenes Secrets You Probably Didn’t Know About The Gentlemen
ca.news.yahoo.com - April 14 at 7:57 AM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

All Headlines

Company Descriptions

Acura Pharmaceuticals logo

Acura Pharmaceuticals

OTCMKTS:ACUR
Acura Pharmaceuticals, Inc., an innovative drug delivery company, engages in the research, development, and commercialization of technologies and products to address safe use of medications in the United States. It offers Oxaydo tablets, a Schedule II narcotic indicated for the management of acute and chronic moderate to severe pain; and Nexafed products, which are pseudoephedrine and acetaminophen tablets that are used as nasal decongestants in various non-prescription and prescription cold, sinus, and allergy products. Acura Pharmaceuticals, Inc. has collaboration and license agreements with Egalet US, Inc. and Egalet Ltd. to manufacture and commercialize Oxaydo products worldwide; and development and commercialization agreement with Abuse Deterrent Pharma, LLC to develop LTX-03, an immediate-release tablets utilizing LIMITx technology. The company was formerly known as Halsey Drug Co., Inc. The company was incorporated in 1935 and is based in Palatine, Illinois. Acura Pharmaceuticals, Inc. operates as a subsidiary of Abuse Deterrent Pharma, LLC.
Auris Medical logo

Auris Medical

NASDAQ:EARS
Auris Medical Holding Ltd. engages in the development of novel products that address unmet medical needs in neurology and central nervous system disorders. It operates through Switzerland and Australia geographical segments. Its product pipeline includes AM-125, AM-201, AM301, Sonsuvi, and Keyzilen. The company was founded by Thomas Meyer in April 2003 and is headquartered in Hamilton, Bermuda.
iCo Therapeutics logo

iCo Therapeutics

OTCMKTS:ICOTF
Satellos Bioscience, Inc. is a regenerative medicine company, which engages in developing novel therapeutics. It operates through a proprietary technology platform, MyoReGenX™ and Leveraging MyoReGenX™, which identify stem cell based regeneration deficits in muscle diseases and develop therapeutic solutions. The company was founded by Frank Gleeson and Michael Rudnicki in 2018 and is headquartered in Toronto, Canada.
International Stem Cell logo

International Stem Cell

OTCMKTS:ISCO
International Stem Cell Corporation, a clinical stage biotechnology company, focuses on the development of therapeutic and biomedical products in the United States, Asia, Europe, and internationally. It develops ISC- hpNSC, a neural stem cell program that has completed the Phase I clinical trial for the treatment of Parkinson's disease, as well as for treating stroke and traumatic brain injury. The company also offers anti-aging skin care products, including ProPlus Advanced Defense Complex, ProPlus Advanced Recovery Complex, ProPlus Eye Firming Complex, ProPlus Neck Firming Complex, ProPlus Advanced Aqueous Treatment, ProPlus Collagen Booster, ProPlus Elastin Booster, and ProPlus Brightening Toner. In addition, it provides human cell culture products comprising human skin cells and reagents for the study of skin disease, toxicology, or wound healing; human cells from the heart and blood vessels, and reagents to study cardiovascular disease and cancer; human bronchial and tracheal cell lines for the study of toxicity, cystic fibrosis, asthma, and pathogenesis; and human mammary epithelial cell lines for the study of breast cancer, three dimensional culture, and carcinogen screening. Its human cell culture products also comprise adult stem cells and reagents for regenerative medicine; human prostate cells and specialized medium to study prostate disease; human renal and bladder cells and media to study renal and bladder diseases; human corneal cells and media for the study of corneal disease; human female reproductive system cells for the study of cellular physiology; human skeletal muscle cells for the study of biology, diabetes, insulin receptor studies, muscle metabolism, muscle tissue repair, and myotube development; and other cell culture reagents and supplements for the growth, staining, and freezing of human cells. International Stem Cell Corporation was founded in 2001 and is headquartered in San Diego, California.
Kaya logo

Kaya

OTCMKTS:KAYS
Kaya Holdings, Inc., a vertically integrated legal cannabis enterprise, produces, distributes, and/or sells a range of cannabis products primarily in the United States. The company offers flower, oils, vape cartridges and cannabis infused confections, baked goods, and beverages. It also operates retail outlets under the Kaya Shack brand name, as well as offers strain specific cannabis cigarettes under the Kaya Buddies name, and strains of cannabis under the Kaya Farms name. In addition, the company provides standing display cases with cannabis intended glassware under the Really Happy Glass brand; and t-shirt designs under the Kaya Gear brand name. The company was formerly known as Alternative Fuels America, Inc. and changed its name to Kaya Holdings, Inc. in April 2015. Kaya Holdings, Inc. was incorporated in 1993 and is headquartered in Fort Lauderdale, Florida.